Location History:
- Mt. View, CA (US) (2004)
- Mountain View, CA (US) (2003 - 2012)
Company Filing History:
12 out of 215 
1 out of 1,974 
Years Active: 2003-2012
Title: Innovations in Anti-Inflammatory Compounds: The Contributions of Brian E. McMaster
Introduction
Brian E. McMaster, based in Mountain View, California, is a prominent inventor known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 12 patents, McMaster has focused primarily on developing compounds that serve as potent antagonists for the CCR1 receptor, which plays a crucial role in inflammatory responses.
Latest Patents
His latest patents include the development of substituted piperazines, which have been confirmed through rigorous animal testing for their anti-inflammatory properties. These compounds, mainly consisting of aryl piperazine derivatives, are not only effective in treating CCR1-mediated diseases but also serve as essential controls in assays aimed at identifying competitive CCR1 antagonists. These innovations have the potential to revolutionize treatment protocols for various inflammatory diseases.
Career Highlights
Throughout his career, Brian McMaster has made significant strides in his field while working with prestigious companies like ChemoCentryx, Inc. and Amgen Inc. His dedication and pioneering spirit have positioned him as an influential figure in pharmaceutical research and development.
Collaborations
McMaster has also collaborated with notable professionals, including Daniel J. Dairaghi and Thomas J. Schall, further enhancing the collaborative spirit that drives innovation in the pharmaceutical sector. These partnerships have played a vital role in advancing research and bringing groundbreaking solutions to the market.
Conclusion
In summary, Brian E. McMaster's work in developing anti-inflammatory compounds represents a significant advancement in medical science. His inventive spirit, combined with collaborative efforts, continues to make an impact in the field, offering hope for effective treatments for inflammatory conditions. As innovations in pharmaceuticals advance, McMaster remains a pivotal figure in this ongoing journey.